ADVERTISEMENT

Angiotensin-converting enzyme inhibitors may increase lung cancer risk

Miriam Davis, PhD   |   Clinical Summary   |   06 December 2022
ADVERTISEMENT

Background

  • Angiotensin-converting enzyme inhibitors (ACEIs) have been used since the 1970s as first-line drugs for the management of hypertension and congestive heart failure, especially in patients with chronic kidney disease or diabetes mellitus.
  • More than 15 ACEIs have been approved by the US FDA.
  • ACEIs are known to have respiratory...

          

March Challenge

Ends in 4d 1h
left
right

Topic Challenges

left
right